Bottom line
How much do JDOC and SHSSX overlap?
55% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 52.9% of JDOC's assets and 52.0% of SHSSX's. They share a meaningful core but differ in the rest of the portfolio.
SHSSX holds far more positions (155 vs 61), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings JDOC and SHSSX have in common
| Holding | % of JDOC | % of SHSSX | Overlap |
|---|---|---|---|
| AbbVie, Inc. | 7.85% | 3.94% | 3.94% |
| Eli Lilly & Co. | 7.76% | 12.29% | 7.76% |
| UnitedHealth Group, Inc. | 5.85% | 6.10% | 5.85% |
| Merck & Co., Inc. | 4.82% | 4.94% | 4.82% |
| Johnson & Johnson | 4.82% | 8.77% | 4.82% |
| AstraZeneca plc | 3.76% | 1.21% | 1.21% |
| Thermo Fisher Scientific, Inc. | 3.73% | 3.02% | 3.02% |
| Abbott Laboratories | 3.11% | 1.97% | 1.97% |
| Stryker Corp. | 2.23% | 1.15% | 1.15% |
| Danaher Corp. | 2.16% | 2.00% | 2.00% |
| Intuitive Surgical, Inc. | 1.93% | 1.95% | 1.93% |
| Edwards Lifesciences Corp. | 1.73% | 2.51% | 1.73% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 0.91% | 0.91% |
| Biogen, Inc. | 1.56% | 1.21% | 1.21% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in JDOC
- Bristol-Myers Squibb Co. — 3.57%
- CVS Health Corp. — 2.83%
- Roche Holding AG — 2.82%
- Novo Nordisk A/S — 2.61%
- GSK plc — 2.47%
- Cencora, Inc. — 2.07%
- Argenx SE — 2.06%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Novartis AG — 1.60%
- Cardinal Health, Inc. — 1.51%
Only in SHSSX
- Gilead Sciences Inc — 4.19%
- Amgen Inc — 3.37%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
- Teva Pharmaceutical Industries Ltd — 1.87%
- Boston Scientific Corp — 1.59%
- Elevance Health Inc — 1.56%
- Argenx Se — 1.26%
- Blackrock Funds III — 1.01%
- Revolution Medicines Inc — 0.96%
- Humana Inc — 0.92%
Asset mix
| Asset type | JDOC | SHSSX |
|---|---|---|
| Stocks | 99.2% | 99.8% |
| Cash & short-term funds | — | 1.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)
Country mix
| Country | JDOC | SHSSX |
|---|---|---|
| US | 75.2% | 93.9% |
| GB | 6.2% | 1.4% |
| CH | 4.4% | 1.4% |
| DK | 4.0% | — |
| JP | 2.5% | 0.2% |
| NL | 2.4% | 1.3% |
| IL | 1.6% | 1.9% |
| DE | 1.9% | 0.1% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / May 29, 2026)
Check another pair
FAQ
How much do JDOC and SHSSX overlap?
What stocks do JDOC and SHSSX have in common?
Should I own both JDOC and SHSSX?
Which holds more stocks, JDOC or SHSSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.